1.Influence of PET/CT positioning on the effect of late-course accelerated hyperfractionated and threc-dimensional conformal radiotherapy for stage Ⅲ lung squamous cell carcinoma
Zhifan SUN ; Yanliang HU ; Chunxia FAN ; Cuixia CAI ; Jiqiu WANG
Chinese Journal of Primary Medicine and Pharmacy 2012;19(17):2590-2591
Objective To investigate the irfluence of PET/CT positioning on the effect of late-course accelerated hyperfractionated and three-dimensional conformal radiotherapy for stage Ⅲ lung squamous cell carcinoma.Methods 79 stage Ⅲ lung squarnous cell carcinoma patients were enrolled and divided into PET/CT group(n =37 cases,PET/CT positioning) and general CT group (n =42 cases,general CT positioning) according to the way of positioning.The conventional fractionated 3 DCRT( about 40 Gy) was used in previous 2/3 time and hyperfractionated( about 1.5 Gy) was used in later 1/3 time.Both groups used chemotherapy as adjuvant therapy.Full course of the treatment was a month or so.And the clinical efficacy and a variety of adverse reactions of the two groups was observed.Results The total rate of remission in PET/CT group were 73.0%,and 71.4% in general CT group,and there was no significant difference in the two groups (x2 =1.347,P > 0.05 ).The major radiation injury were radioactive pulmonary injury and tracheal damage,incidence rates were 56.8%and 57.1% in acute stage,and there was no significant difference in the two groups( x2 =2.178,P > 0.05 ) ; but in late stage 69.0% in general CT group was significantly higher than 62.2% in PET/CT group(x2 =4.142,P <0.05).Ater followed-up 1 year,the recurrence rate of hillar and mediastinal lymph node in PET/CT group was 43.7%,lower than that of the general CT group( 59.4% ) ( x2 =4.732,P < 0.05 ).Conclusion PET/CT positioning in late-course accelerated hyperfractionated and three-dimensional conformal radiotherapy for stage Ⅲ lung squamous cell carcinoma could reduce late stage radioactive pulmonary injury and tracheal damage,lower the recurrence rate of hillar and mediastinal lymph node.
2.Genetic mapping and mutation analysis in a family with paroxysmal kinesigenic dystonia
Zhifan ZHOU ; Nan LI ; Junling WANG ; Zhengmao HU ; Kun XIA ; Beisha TANG
Chinese Journal of Neurology 2010;43(6):394-399
Objective To study the clinical characteristics and genetic cause of a Chinese family affected with paroxysmal kinesigenic dystonia(PKD).Methods The detailed clinical data and the blood samples of the affected patients with PKD and their relatives were collected.After genomic DNA was extracted from blood leukocytes,target linkage analysis Was performed using multiplex PCR by microsatellite marker's located in the reported critical region on chromosome 16.All exons and flanking regions of SCNN1G and ITGAL genes were amplified by PCR-sequence.Results In this three-generation 12 member family,5 individuals have been diagnosed as PKD.Target linkage analysis suggested the disease gene linked to chromosome 16.between D16S3396 and D16S3057 with two-point LOD score of 1.47 at recombination fraction(θ)=0.0.All affected individuals shared a common haplotype which co-segregated with the phenotype.Except for 8 reported SNPs,no pathologic sequence variants were found in candidate genes SCNN1G and ITGAL.Conclusions The studied family is genetically linked to the reported critical locus of PKD on chromosome 16.SCNN1G and ITGAL were ruled out as the causative genes for the studied pedigree.Further genetic analysis in this family may reveal new genetic cause responsible for PKD.
3.Progress in diagnosis and treatment of children with laryngopharyngeal reflux
Huiqin ZENG ; Lingyun HOU ; Xiaoshan DAI ; Zhifan HU ; Jinzhun WU
Chinese Journal of Applied Clinical Pediatrics 2018;33(7):558-560
Laryngopharyngeal reflux is an independent disease that affects the quality of life in children,but its pathogenesis is not clear and its diagnostic criteria is not unified.With the reports of laryngopharyngeal reflux continuing to emerge in recent years,this study aims to review the progress in pathogenesis,diagnosis and treatment of laryngopharyngeal reflux in children.
4.Anti-aging effects of chlorpropamide depend on mitochondrial complex-II and the production of mitochondrial reactive oxygen species.
Zhifan MAO ; Wenwen LIU ; Yunyuan HUANG ; Tianyue SUN ; Keting BAO ; Jiali FENG ; Alexey MOSKALEV ; Zelan HU ; Jian LI
Acta Pharmaceutica Sinica B 2022;12(2):665-677
Sulfonylureas are widely used oral anti-diabetic drugs. However, its long-term usage effects on patients' lifespan remain controversial, with no reports of influence on animal longevity. Hence, the anti-aging effects of chlorpropamide along with glimepiride, glibenclamide, and tolbutamide were studied with special emphasis on the interaction of chlorpropamide with mitochondrial ATP-sensitive K+ (mitoK-ATP) channels and mitochondrial complex II. Chlorpropamide delayed aging in Caenorhabditis elegans, human lung fibroblast MRC-5 cells and reduced doxorubicin-induced senescence in both MRC-5 cells and mice. In addition, the mitochondrial membrane potential and ATP levels were significantly increased in chlorpropamide-treated worms, which is consistent with the function of its reported targets, mitoK-ATP channels. Increased levels of mitochondrial reactive oxygen species (mtROS) were observed in chlorpropamide-treated worms. Moreover, the lifespan extension by chlorpropamide required complex II and increased mtROS levels, indicating that chlorpropamide acts on complex II directly or indirectly via mitoK-ATP to increase the production of mtROS as a pro-longevity signal. This study provides mechanistic insight into the anti-aging effects of sulfonylureas in C. elegans.